InflaRx IFRX
NASDAQ IFRX
$2.05 -0.04 (-1.91%)
As of: Sep 10, 2026 · 3:59 PM EDT

InflaRx (IFRX) Market Capitalization (2017 - 2026)

InflaRx's (IFRX) quarterly Market Capitalization came in at $161.9 million in Q2 2026, up 245.37% year-over-year from $46.9 million in Q2 2025, and up 151.69% quarter-over-quarter from $64.3 million in Q1 2026.

Analysis

InflaRx (IFRX) Market Capitalization (2017 - 2026) Analysis & Trends

InflaRx has disclosed Market Capitalization across 10 years of filings, most recently posting $161.9 million for Q2 2026.

  • In Q2 2026, Market Capitalization rose 245.37% year-over-year to $161.9 million; the TTM figure through Jun 2026 stood at $161.9 million (up 245.37% YoY), while the FY2025 annual figure was $73.0 million, down 50.19% from the prior year.
  • Market Capitalization came in at $161.9 million for Q2 2026 at InflaRx, up from $64.3 million in the prior quarter.
  • In the past five years, Market Capitalization ranged from a high of $199.4 million in Q2 2023 to a low of $46.9 million in Q2 2025.
  • Average Market Capitalization over 5 years is $101.8 million, with a median of $90.4 million recorded in 2024.
  • Year-over-year, Market Capitalization sank 54.24% in 2025 and soared 245.37% in 2026.
  • Over 5 years, Market Capitalization stood at $138.6 million in 2022, then plunged by 30.74% to $96.0 million in 2023, then surged by 52.74% to $146.6 million in 2024, then tumbled by 50.19% to $73.0 million in 2025, then surged by 121.78% to $161.9 million in 2026.
  • Per Business Quant data, the three most recent Market Capitalization figures were $161.9 million in Q2 2026, $64.3 million in Q1 2026, and $73.0 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn
10 InflaRx 139.29 Mn -44.96 Mn 2.74 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 161.94 Mn
Mar 31, 2026 64.34 Mn
Dec 31, 2025 73.02 Mn
Sep 30, 2025 79.53 Mn
Jun 30, 2025 46.89 Mn
Mar 31, 2025 60.54 Mn
Dec 31, 2024 146.60 Mn
Sep 30, 2024 90.09 Mn
Jun 30, 2024 102.46 Mn
Mar 31, 2024 90.68 Mn
Dec 31, 2023 95.98 Mn
Sep 30, 2023 133.22 Mn
Jun 30, 2023 199.38 Mn
Mar 31, 2023 86.73 Mn
Dec 31, 2022 138.58 Mn
Sep 30, 2022 116.70 Mn
Jun 30, 2022 64.10 Mn
Mar 31, 2022 80.89 Mn
Dec 31, 2021 210.41 Mn
Sep 30, 2021 73.11 Mn